WP
MRSN

Woodline Partners’s Mersana Therapeutics MRSN Stock Holding History

Woodline Partners’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,424
Closed -$150K – 1013
2025
Q1 		$150K Hold
17,424
– – ﹤0.01% 883
2024
Q4 		$623K Buy
17,424
+82
+0.5% +$4.24K ﹤0.01% 813
2024
Q3 		$819K Sell
17,342
-41,350
-70% -$1.82M 0.01% 518
2024
Q2 		$2.95M Sell
58,692
-58,693
-50% -$4.24M 0.03% 386
2024
Q1 		$13.1M Buy
+117,385
New +$11.7M 0.12% 229
2023
Q4 		– Sell
-52,080
Closed -$1.65M – 594
2023
Q3 		$1.65M Buy
+52,080
New +$2.48M 0.02% 414
2023
Q1 		– Sell
-20,936
Closed -$3.07M – 726
2022
Q4 		$3.07M Buy
+20,936
New +$3.54M 0.04% 396
2022
Q3 		– Sell
-126,463
Closed -$14.6M – 798
2022
Q2 		$14.6M Buy
+126,463
New +$11.9M 0.24% 142
2020
Q3 		– Sell
-10,686
Closed -$6.25M – 202
2020
Q2 		$6.25M Buy
+10,686
New +$3.65M 0.25% 96

Other funds holding MRSN

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return